event,time
39 years old ,0
female ,0
palpable mass on right breast ,-168
Hodgkin lymphoma ,-6336
chemotherapy ,-6336
mantle field radiation ,-6336
inflammatory colitis ,-6336
mesalazine ,-336
breast cancer ,-168
invasive ductal carcinoma ,-168
triple-negative phenotype ,-168
MIB1 85% ,-168
staging CT scan ,-168
neoadjuvant chemotherapy ,-112
paclitaxel ,-112
carboplatin ,-112
port-Ã -cath insertion ,-84
subcutaneous cellulitis ,-56
colliquative necrosis ,-56
fever ,-56
elevated white blood cell count ,-56
neutrophilia ,-56
elevated C-reactive protein ,-56
broad-spectrum i.v. antibiotic therapy ,-56
piperacillin/tazobactam ,-56
daptomycin ,-56
PORT rimotion ,-56
necrosectomy ,-56
defervescence ,-48
improvement in subcutaneous cellulitis ,-48
improvement in blood works ,-48
febrile seizure ,-40
WBC rise ,-40
worsening of skin lesion ,-40
second necrosectomy ,-40
peripheral blood cultures ,-40
skin plug ,-40
i.v. catheter tip ,-40
Klebsiella pneumoniae ,-40
meropenem ,-40
levofloxacin ,-40
antibiotic therapy ,-40
chest/abdomen CT scan ,-40
mediastinitis ,-40
bilateral pleural effusion ,-40
left pulmonary atelectasis ,-40
thoracoscopy ,-32
pleural and mediastinal drainage ,-32
sepsis ,-32
broad-spectrum antibiotic ,-32
antifungal therapy ,-32
hemodynamic support ,-32
non-invasive ventilation ,-32
intensive inflammatory infiltrate ,-32
neutrophils ,-32
PG ,-32
systemic methylprednisolone ,-32
topical cyclosporine ,-32
seriate chest X-ray ,-24
progressive resolution of mediastinitis ,-24
progressive resolution of pleural effusion ,-24
wound improvement ,-24
scar ,-24
progressive normalization of blood count ,-24
progressive normalization of flogosis index ,-24
breast ultrasound ,-16
no change in the dimension of the lump ,-16
multidisciplinary meeting ,-16
right mastectomy ,-16
axillary dissection ,-16
breast surgical wound healing ,-16
fibroelastosis ,-16
chronic inflammation ,-16
isolated neoplastic cells ,-16
restaging brain/chest/abdomen CT ,-16
no distant metastasis ,-16
BRCA ,-16
p53 mutation tests ,-16
autologous skin graft ,0
no further complications ,0
PICC implant ,0
chemotherapy ,0
carboplatin ,0
paclitaxel ,0
dose reduction ,0
good tolerance ,24
follow-up ,168
TILs ,-168
moderate infiltrate ,-16
